Abnormal expression of bcl‐2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4‐nitroquinoline 1‐oxide
- 24 November 2005
- journal article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 86 (6) , 375-382
Abstract
Summary: 4‐Nitroquinoline 1‐oxide (4NQO)‐induced rat tongue carcinogenesis is a useful model for studying oral squamous cell carcinoma. The aim of this study was to investigate the expression of bcl‐2 and bax during tongue carcinogenesis induced by 4NQO. Male Wistar rats were distributed into three groups of 10 animals each and treated with 50 ppm 4NQO solution through their drinking water for 4, 12 or 20 weeks. Ten animals were used as negative control. Although no histological changes were induced in the epithelium after 4 weeks of carcinogen exposure, bcl‐2 and bax were over‐expressed (P < 0.01) in all layers of the ‘normal’ epithelium. The expression levels were the same in all layers of epithelium for both the antibodies used (bcl‐2 or bax). In dysplastic lesions at 12 weeks following carcinogen administration, the levels of bcl‐2 and bax expression did not increase when compared to negative control with the immunoreactivity for bcl‐2 being restricted to the superficial layer of epithelium. In well‐differentiated squamous cell carcinoma induced after 20 weeks of treatment with 4NQO, bcl‐2 was expressed in some cells of tumour islands. On the other hand, immunostaining for bax was widely observed at the tumour nests. The labelling index for bcl‐2 and bax showed an increase (P < 0.05) after only 4 weeks of 4NQO administration. In conclusion, our results suggest that abnormalities in the apoptosis pathways are associated with the development of persistent clones of mutated‐epithelial cells in the oral mucosa. Bcl‐2 and bax expression appears to be associated with a risk factor in the progression of oral cancer.Keywords
This publication has 38 references indexed in Scilit:
- Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasiasOral Oncology, 2002
- Oral and Maxillofacial Pathology: Bcl‐2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistryOral Diseases, 2000
- Apoptosis-associated proteins and the development of oral squamous cell carcinomaOral Oncology, 1999
- Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesionsCancer Letters, 1996
- Detection of BCL-2 RNA in low grade tumours of the urinary bladderEuropean Journal of Cancer, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Cancer in Developing Countries: Opportunity and ChallengeJNCI: Journal of the National Cancer Institute, 1993
- Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinomaInternational Journal of Cancer, 1993
- Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking waterOral Surgery, Oral Medicine, Oral Pathology, 1985
- Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocationNature, 1985